162 related articles for article (PubMed ID: 12502719)
1. The mmaA2 gene of Mycobacterium tuberculosis encodes the distal cyclopropane synthase of the alpha-mycolic acid.
Glickman MS
J Biol Chem; 2003 Mar; 278(10):7844-9. PubMed ID: 12502719
[TBL] [Abstract][Full Text] [Related]
2. Redundant function of cmaA2 and mmaA2 in Mycobacterium tuberculosis cis cyclopropanation of oxygenated mycolates.
Barkan D; Rao V; Sukenick GD; Glickman MS
J Bacteriol; 2010 Jul; 192(14):3661-8. PubMed ID: 20472794
[TBL] [Abstract][Full Text] [Related]
3. The Mycobacterium tuberculosis cmaA2 gene encodes a mycolic acid trans-cyclopropane synthetase.
Glickman MS; Cahill SM; Jacobs WR
J Biol Chem; 2001 Jan; 276(3):2228-33. PubMed ID: 11092877
[TBL] [Abstract][Full Text] [Related]
4. Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence.
Rao V; Gao F; Chen B; Jacobs WR; Glickman MS
J Clin Invest; 2006 Jun; 116(6):1660-7. PubMed ID: 16741578
[TBL] [Abstract][Full Text] [Related]
5. Thiacetazone, an antitubercular drug that inhibits cyclopropanation of cell wall mycolic acids in mycobacteria.
Alahari A; Trivelli X; Guérardel Y; Dover LG; Besra GS; Sacchettini JC; Reynolds RC; Coxon GD; Kremer L
PLoS One; 2007 Dec; 2(12):e1343. PubMed ID: 18094751
[TBL] [Abstract][Full Text] [Related]
6. The biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis. Identification and functional analysis of CMAS-2.
George KM; Yuan Y; Sherman DR; Barry CE
J Biol Chem; 1995 Nov; 270(45):27292-8. PubMed ID: 7592990
[TBL] [Abstract][Full Text] [Related]
7. MMAS-1, the branch point between cis- and trans-cyclopropane-containing oxygenated mycolates in Mycobacterium tuberculosis.
Yuan Y; Crane DC; Musser JM; Sreevatsan S; Barry CE
J Biol Chem; 1997 Apr; 272(15):10041-9. PubMed ID: 9092547
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice.
Barkan D; Hedhli D; Yan HG; Huygen K; Glickman MS
Infect Immun; 2012 Jun; 80(6):1958-68. PubMed ID: 22431648
[TBL] [Abstract][Full Text] [Related]
9. Crystal structures of mycolic acid cyclopropane synthases from Mycobacterium tuberculosis.
Huang CC; Smith CV; Glickman MS; Jacobs WR; Sacchettini JC
J Biol Chem; 2002 Mar; 277(13):11559-69. PubMed ID: 11756461
[TBL] [Abstract][Full Text] [Related]
10. Temperature-dependent regulation of mycolic acid cyclopropanation in saprophytic mycobacteria: role of the Mycobacterium smegmatis 1351 gene (MSMEG_1351) in CIS-cyclopropanation of alpha-mycolates.
Alibaud L; Alahari A; Trivelli X; Ojha AK; Hatfull GF; Guerardel Y; Kremer L
J Biol Chem; 2010 Jul; 285(28):21698-707. PubMed ID: 20457615
[TBL] [Abstract][Full Text] [Related]
11. Free enzyme dynamics of CmaA3 and CmaA2 cyclopropane mycolic acid synthases from Mycobacterium tuberculosis: Insights into residues with potential significance in cyclopropanation.
Annaraj P D; Kadirvel P; Subramanian A; Anishetty S
J Mol Graph Model; 2019 Sep; 91():61-71. PubMed ID: 31181453
[TBL] [Abstract][Full Text] [Related]
12. Identification of a gene involved in the biosynthesis of cyclopropanated mycolic acids in Mycobacterium tuberculosis.
Yuan Y; Lee RE; Besra GS; Belisle JT; Barry CE
Proc Natl Acad Sci U S A; 1995 Jul; 92(14):6630-4. PubMed ID: 7604045
[TBL] [Abstract][Full Text] [Related]
13. Separation and characterization of individual mycolic acids in representative mycobacteria.
Watanabe M; Aoyagi Y; Ridell M; Minnikin DE
Microbiology (Reading); 2001 Jul; 147(Pt 7):1825-1837. PubMed ID: 11429460
[TBL] [Abstract][Full Text] [Related]
14. Designing novel inhibitors against cyclopropane mycolic acid synthase 3 (PcaA): targeting dormant state of
Verma J; Subbarao N
J Biomol Struct Dyn; 2021 Oct; 39(17):6339-6354. PubMed ID: 32715934
[No Abstract] [Full Text] [Related]
15. Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule.
Rao V; Fujiwara N; Porcelli SA; Glickman MS
J Exp Med; 2005 Feb; 201(4):535-43. PubMed ID: 15710652
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of mycobacterial PcaA inhibits mycolic acid cyclopropanation: consequences for intracellular survival and for phagosome maturation block.
Corrales RM; Molle V; Leiba J; Mourey L; de Chastellier C; Kremer L
J Biol Chem; 2012 Jul; 287(31):26187-99. PubMed ID: 22621931
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics investigation of the active site dynamics of mycobacterial cyclopropane synthase during various stages of the cyclopropanation process.
Choudhury C; Deva Priyakumar U; Sastry GN
J Struct Biol; 2014 Jul; 187(1):38-48. PubMed ID: 24780591
[TBL] [Abstract][Full Text] [Related]
18. A common mechanism for the biosynthesis of methoxy and cyclopropyl mycolic acids in Mycobacterium tuberculosis.
Yuan Y; Barry CE
Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12828-33. PubMed ID: 8917504
[TBL] [Abstract][Full Text] [Related]
19. A novel mycolic acid cyclopropane synthetase is required for cording, persistence, and virulence of Mycobacterium tuberculosis.
Glickman MS; Cox JS; Jacobs WR
Mol Cell; 2000 Apr; 5(4):717-27. PubMed ID: 10882107
[TBL] [Abstract][Full Text] [Related]
20. Conformational folding of mycobacterial methoxy- and ketomycolic acids facilitated by α-methyl trans-cyclopropane groups rather than cis-cyclopropane units.
Villeneuve M; Kawai M; Horiuchi K; Watanabe M; Aoyagi Y; Hitotsuyanagi Y; Takeya K; Gouda H; Hirono S; Minnikin DE
Microbiology (Reading); 2013 Nov; 159(Pt 11):2405-2415. PubMed ID: 24014663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
